Stocks

Pharma Stock Market Review

Latest Pharma Stock Updates

covid shares

Covid Vaccine Shares Hit by US Administration Decision to Wave Patents

The announced temporary waiver of COVID-19 vaccine patents by Joe Biden’s administration has hit vaccine maker shares and raised serious

decorative

Evotec Invests in Oxford University Spinout Cell Therapy Company OxVax

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) revealed that it has invested in OxVax, a new immuno-oncology organization

drug resistant bacteria

Phico Therapeutics Awarded up to $18.2 Million Funding to Advance Antibacterial Therapy

Phico Therapeutics (‘Phico’), a British biotech company developing engineered phage technologies as the foundation of a new wave of antibiotics

Thermo Fisher to Acquire CRO giant PPD for $17.4 Billion in Cash

Thermo Fisher Scientific expands clinical research service offering to pharma and biotech customers with a CRO giant PPD acquisition. Thermo

Evotec Launches the First Translational BRIDGE in Germany in Collaboration with Bristol-Myers

Evotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $

Phenomic AI starts with $6M using AI/ML for Targeting the Tumor Stroma

Phenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6

letter of intent

Enzolytics and BioClonetics intent to merge sends stock parabolic

Enzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of

cardiovascular disease

BMS boosts cardiovascular pipeline with $13.1 Billion MyoKardia buy

Bristol Myers Squibb is strengthening its cardiovascular pipeline through a $13.1 Billion acquisition of biotech firm MyoKardia. The $13.1 Billion

Biotech firms raise $12.6B investment in H1 of 2020

Biotechnology has spearheaded the healthcare industry in investment action from private equity and venture capital during the first half of

venture capital decorative

BioMed Raises $177M to Accelerate Next-Gen Biologics Development

Harbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,

Advertisement